How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Healthcare and Pharmaceuticals · Forecast 2027–2033
Live Animal In Vivo Imaging System Market
- By Imaging Technology: Bioluminescence Imaging, Fluorescence Imaging, X-ray Imaging, Magnetic Resonance Imaging (MRI), Positron Emission Tomography (PET), Computed Tomography (CT)
- By Animal Model: Rodents (Mice and Rats), Zebrafish, Rabbits, Non-human Primates, Guinea Pigs
- By Application: Oncology Research, Cardiovascular Research, Neurological Research, Infectious Disease Research, Drug Discovery and Development
- By End User: Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, Contract Research Organizations (CROs), Hospitals and Clinical Research Centers
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Bioluminescence Imaging leads By Imaging Technology at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 15 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
11 chapters · 282 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.63 →
- 10 Competitive Landscape 5 sections p.169 →
- 11 Company Profiles 15 players: SWOT & benchmarking p.177 →
Full report · locked preview
Everything inside the Live Animal In Vivo Imaging System Market report
A complete, evidence-based study - 11 chapters and 118 sections covering market size, segmentation across 4 axes, regional analysis and 15 company profiles, forecast to 2033.
Segmentation covered
Imaging Technology 6
Animal Model 5
Application 5
End User 4
Companies profiled
PerkinElmer Inc.
Bruker Corporation
Miltenyi Biotec
FUJIFILM VisualSonics Inc.
Sofie Biosciences
Spectral Instruments Imaging
BioSpace Solutions
VisEn Medical Inc.
Caliper Life Sciences (now part of PerkinElmer)
Mediso Medical Imaging Systems
Aspect Imaging
Imaging Research Inc.
+3 more
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
15 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →PerkinElmer Inc.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →Bruker Corporation
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →Miltenyi Biotec
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →FUJIFILM VisualSonics Inc.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →Sofie Biosciences
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →Spectral Instruments Imaging
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.184 →BioSpace Solutions
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.191 →VisEn Medical Inc.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →Caliper Life Sciences (now part of PerkinElmer)
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →Mediso Medical Imaging Systems
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →Aspect Imaging
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.214 →Imaging Research Inc.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.220 →Trifoil Imaging
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.227 →ART Advanced Research Technologies
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.232 →Biospace Lab
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.238 →Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Global · 2025–2033
$2,413M by 2033 · 11.5% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Bioluminescence Imaging33.9
- Fluorescence Imaging12.0
- X-ray Imaging17.7
- Magnetic Resonance Imaging (MRI)12.9
- Positron Emission Tomography (PET)11.1
- Computed Tomography (CT)12.3
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$333.5M → $731.3M · 10.3%
Europe$232.4M → $562.1M · 11.7%
Asia Pacific$212.2M → $556.1M · 12.8%
Latin America$131.4M → $293.0M · 10.5%
Middle East and Africa$101.1M → $223.3M · 10.4%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →11.442026
11.452027
11.462028
11.492029
11.502030
11.492031
11.522032
11.532033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- PerkinElmer Inc.22.9
- Bruker Corporation17.0
- Miltenyi Biotec9.1
- FUJIFILM VisualSonics Inc.9.4
- Sofie Biosciences8.8
- Spectral Instruments Imaging4.8
- Others28.0
Segment contribution to growth (%)
Fig. 18 · p.39 →Imaging Technology35.6%
Animal Model21.8%
Application17.8%
End User24.7%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America30.9
- Europe23.8
- Asia Pacific23.5
- Latin America12.4
- Middle East and Africa9.4
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| PerkinElmer Inc. | 86 | 98 | 76 | 90 | 81 | 89 | 87 |
| Bruker Corporation | 74 | 68 | 82 | 77 | 78 | 81 | 77 |
| Miltenyi Biotec | 71 | 74 | 86 | 87 | 78 | 68 | 77 |
| FUJIFILM VisualSonics Inc. | 75 | 60 | 80 | 74 | 66 | 74 | 72 |
| Sofie Biosciences | 62 | 68 | 62 | 75 | 74 | 67 | 68 |
| Spectral Instruments Imaging | 67 | 59 | 71 | 58 | 62 | 49 | 61 |
| BioSpace Solutions | 56 | 51 | 52 | 43 | 42 | 63 | 51 |
| VisEn Medical Inc. | 35 | 37 | 47 | 42 | 54 | 55 | 45 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- PerkinElmer Inc.
- Bruker Corporation
- Miltenyi Biotec
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| PerkinElmer Inc. | ◐ | ✓ | ✓ | ◐ | ✓ | ✓ |
| Bruker Corporation | ◐ | ◐ | ✓ | ◐ | ◐ | ✓ |
| Miltenyi Biotec | ✓ | ◐ | ✓ | ✓ | ◐ | ◐ |
| FUJIFILM VisualSonics Inc. | ✓ | ◐ | ◐ | ✓ | ◐ | ✓ |
| Sofie Biosciences | ✓ | ◐ | ◐ | ◐ | ✓ | − |
| Spectral Instruments Imaging | ◐ | − | ◐ | ◐ | − | − |
| BioSpace Solutions | ◐ | − | − | − | − | − |
| VisEn Medical Inc. | − | − | − | ◐ | ◐ | − |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1PerkinElmer Inc.87
2Bruker Corporation77
3Miltenyi Biotec77
4FUJIFILM VisualSonics Inc.72
5Sofie Biosciences68
6Spectral Instruments Imaging61
7BioSpace Solutions51
8VisEn Medical Inc.45
Competitive tiers
§8.4 · p.172 →Leader1
Set the pace on share, breadth and innovation.
PerkinElmer Inc.
Challenger4
Strong scale, closing on the leaders.
Bruker CorporationMiltenyi BiotecFUJIFILM VisualSonics Inc.Sofie Biosciences
Contender1
Focused players with pockets of strength.
Spectral Instruments Imaging
Niche2
Specialists in a single segment or region.
BioSpace SolutionsVisEn Medical Inc.
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Go-to-market strategy
Land Imaging Technology in North America, then scale across Live Animal In Vivo Imaging System Market — a $260M beachhead inside a $3.79B market.
Beachhead (SOM)$260Mobtainable near-term
Serviceable (SAM)$1.47Breachable market
Primary motionDirect + partner-ledgo-to-market
Time to scale4 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion88 fit
Bioluminescence Imaging
Best fit — highest urgency & budget in Imaging Technology.
Economic buyer75 fit
Fluorescence Imaging
Strong fit — clear ROI and a fast path to value.
End user64 fit
X-ray Imaging
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Imaging Technology in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Animal Model & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + Application
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales44%
Partner / channel31%
Digital / self-serve18%
Marketplaces7%
Positioning & messaging
§GTM 2 · p.194 →For Imaging Technology leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Live Animal In Vivo Imaging System Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified42%
Sales qualified24%
Evaluation15%
Closed-won5%
$12.5KCAC
$58KLTV
4.6:1LTV : CAC
< 4 moCAC payback
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Investment thesis
Live Animal In Vivo Imaging System Market is a resilient opportunity — $5.84B by 2033, compounding at 5.5%.
TAM · 2025$3.81Btoday
TAM · 2033$5.84Bforecast
CAGR5.5%2027–2033
Cumulative$42.9Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$5.84BTotal addressable market
SAM$2.06BServiceable available market
SOM$380MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →5.5% CAGR
Demand compounds through 2033, outpacing GDP across Imaging Technology.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Imaging Technology moving from early to mainstream — durable secular demand.
Consolidation upside
15+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$5.84BLarge & growingTAM by 2033 at 5.5% CAGR
$2.06BServiceable nowreachable with today’s model
$380MBeachhead winobtainable near-term share
15+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$4.56BBear3.6% CAGR
$5.84BBase5.5% CAGR
$7.48BBull7.2% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Animal Model optionality
- Customer concentrationBroaden installed base beyond top accounts
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Board pack · executive summary
Live Animal In Vivo Imaging System Market — a $709M market by 2033. Plan: grow share from 7.9% to 17.2%.
Market size · 2033$709Mtotal addressable
Market CAGR4.9%2027–2033
Target share17.2%from 7.9% today
Revenue ambition$122Mby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 7.9% | 17.2% | Ahead |
| Revenue | $54M | $122M | On track |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | At risk |
| Segment coverage | 2 of 4 axes | 4 of 4 axes | Behind |
| Gross margin | 29.9% | 41.1% | At risk |
| Customer retention | 90.5% | 92.4% | Behind |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Imaging Technology
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build Animal Model capability
A defensible second engine — invest in Animal Model to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Imaging Technology share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Animal Model
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $18M capacity & capability investment
- Greenlight bolt-on M&A in Animal Model
- Authorise North America expansion plan
- Fund R&D program for Imaging Technology leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownAt risk
- Competitive share lossOn track
- Input-cost & supply riskOn track
- Regulatory / policy changeOn track
- Execution & talentOn track
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Sales deck · value proposition
Win the Live Animal In Vivo Imaging System Market conversation — a $2.66B market you can size, segment and defend in minutes.
Market size · 2033$2.66Btotal opportunity
Growth5.3%CAGR to 2033
Addressable buyers1,774+accounts in scope
Typical ROI4.6×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Imaging Technology
Goal Grow share in Imaging Technology
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →4.6×return on cost, year one
< 4 mopayback period
$56K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
15+players profiled in this market
Coverage includes
PerkinElmer Inc.Bruker CorporationMiltenyi BiotecFUJIFILM VisualSonics Inc.Sofie BiosciencesSpectral Instruments ImagingBioSpace SolutionsVisEn Medical Inc.+7 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Live Animal In Vivo Imaging System Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
Live Animal In Vivo Imaging System Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Healthcare and Pharmaceuticals · scroll →Live and Attenuated Vaccine Market
Market size, share, segmentation and regional forecast.
$6.1B market · 2025 base year
View reportLiuwei Dihuang Pill Market
Market size, share, segmentation and regional forecast.
$4.7B market · 2025 base year
View reportLiuweidihuang Market
Market size, share, segmentation and regional forecast.
$1.6B market · 2025 base year
View reportLiuhe Dingzhong Pills Market
Market size, share, segmentation and regional forecast.
$3.9B market · 2025 base year
View reportLithotripsy Treatment Equipment Market
Market size, share, segmentation and regional forecast.
$2.5B market · 2025 base year
View reportLithotripsy Laser Market
Market size, share, segmentation and regional forecast.
$1.1B market · 2025 base year
View reportLithotomy Balloon Catheter Market
Market size, share, segmentation and regional forecast.
$3.2B market · 2025 base year
View reportLithospermum Root Extract Market
Market size, share, segmentation and regional forecast.
$4.5B market · 2025 base year
View reportLithospermum Erythrorhizon Extract Market
Market size, share, segmentation and regional forecast.
$3.6B market · 2025 base year
View reportLithium Therapy Market
Market size, share, segmentation and regional forecast.
$3.0B market · 2025 base year
View reportLithium Orotate Supplement Market
Market size, share, segmentation and regional forecast.
$5.4B market · 2025 base year
View reportLithium Molecular Sieve for Oxygen Concentrators Market
Market size, share, segmentation and regional forecast.
$5.0B market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report is readable online in full. Downloadable formats are available as optional $99 add-ons: a formatted PDF and a fully editable XLSX containing all underlying data tables - so you can re-chart, re-model, or drop any figure straight into your own deck.